Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00029120 · ClinicalTrials.gov registry record

Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
450
Enrollment target

NCT00029120 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 450 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00029120 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
450 participants
Enrollment target

Study Summary

The purpose of this study is to examine how a part of the brain called the hippocampus contributes to memory changes that occur with aging and Alzheimer's disease (AD). Memory problems are the most important early symptoms of AD. The hippocampal region of the brain may be responsible for many age- and AD-related memory disorders. This study will use magnetic resonance imaging (MRI) scans to examine the structure, chemical composition, and function of the hippocampus in participants with AD, participants with mild memory problems, participants who are healthy but are at risk for AD, and healthy volunteers. Participants in this study will undergo MRI scans of the brain. During the MRI, participants will perform memory tests to demonstrate hippocampal functioning.

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2001-12-18
Est. Completion 2008-04-21

What the Registry Record Tells You About NCT00029120

The ClinicalTrials.gov registry entry for NCT00029120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00029120 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00029120 about?

NCT00029120 is a clinical study titled "Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder". The purpose of this study is to examine how a part of the brain called the hippocampus contributes to memory changes that occur with aging and Alzheimer's disease (AD). Memory problems are the most important early symptoms of AD. The hippocampal region of the brain may be responsible for many age- ...

What is the current status of trial NCT00029120?

This trial is currently completed. The enrollment target is 450 participants. The study started on 2001-12-18. Estimated completion is 2008-04-21.

Who is sponsoring clinical trial NCT00029120?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.